Clinical trial
Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in…
NCT00222222 · Universitätsmedizin Mannheim, Other · Completed
Key facts
| NCT number | NCT00222222 |
|---|---|
| Title | Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With Sepsis |
| Official title | Mediators of Inflammation, Prognostic Markers and Genetic Polymorphisms in Patients With Sepsis |
| Lead sponsor | Universitätsmedizin Mannheim, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Sepsis |
| Intervention type | Procedure |
| Interventions | vein puncture |
| Enrollment | 105 |
| Start date | Mar 1, 2003 |
| Primary completion | Dec 1, 2011 |
| Completion | Dec 1, 2011 |
| First posted | Sep 22, 2005 |
| Last update posted | Feb 16, 2012 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: